top
请输入关键字
确定
请输入关键字
确定
Database
媒体中心
联系我们
CN
EN
JP
KR
关于我们
公司简介
发展历程
管理团队
企业文化
社会责任
招贤纳士
抗体新药开发
千鼠万抗
抗体发现技术平台
产品管线
临床阶段资产
临床前阶段资产
RenMice平台
全人抗体小鼠RenMab
共轻链抗体小鼠RenLite
纳米抗体小鼠RenNano
模型资源
基因人源化鼠
基因敲除鼠
免疫缺陷鼠
老龄鼠
工具鼠
疾病模型鼠
细胞模型
药理药效
治疗领域
服务种类
分子类型
技术
基因编辑
基于模型
基于技术
基于策略
动物代养
动物保种
动物净化
全球合作
投资者关系
股票信息
业绩报告
招股文件
公告及通函
企业管治
投资者日志
电邮通知
投资者关系联络
首页
模型资源
动物/细胞资源
免疫缺陷鼠
B-NDG系列免疫缺陷小鼠
动物/细胞资源
人源化动物模型
免疫检查点人源化小鼠
细胞因子人源化
GPCR人源化小鼠
其他人源化小鼠
免疫缺陷鼠
B-NDG系列免疫缺陷小鼠
其他免疫缺陷鼠
基因敲除鼠
靶点验证KO鼠
其它KO鼠
老龄鼠
老龄鼠
工具鼠
Cre工具鼠
Reporter工具鼠
其他工具鼠
疾病模型鼠
肿瘤细胞系
人源化细胞系
鼠源化细胞系
其它细胞系
Reporter细胞系
疾病模型资源
肿瘤类
同种移植模型
自发型肿瘤模型
异种移植模型
代谢类
NASH小鼠模型
肥胖和糖尿病模型
急性肝损伤小鼠模型
肝纤维化模型
动脉粥样硬化模型
慢性肾病(CKD)模型
炎症和自免类
类风湿性关节炎(RA)疾病模型
特应性皮炎(AD)模型
肺纤维化模型
系统性红斑狼疮(SLE)模型
肺炎模型
骨质疏松小鼠模型
迟发性超敏反应(DTH)疾病模型
银屑病小鼠模型
哮喘(Asthma)模型
多发性硬化(MS)模型
炎症性肠病( IBD)模型
B-NDG系列免疫缺陷小鼠
产品编号
常规命名
应用领域
110586
B-NDG mice
Immune reconstitution, CDX, transplantation, drug evaluation
110586
B-NDG mice-PDX
Immune reconstitution, CDX, transplantation, drug evaluation
110587
B-NDG nude mice
Human immune system reconstitution
110601
B-NDG B2m KO mice plus
Reduce PBMC reconstitution GVHD response and prolong experimental window
110600
B-NDG hIL15 mice
Promote human NK cell differentiation
110599
B-NDG HLA-A2.1 mice
Vaccine study
110596
B-NDG hIL6 mice
Promotes human monocyte differentiation
110590
B-NDG hTHPO mice
Without irradiation, it reduces the damage caused by irradiation to mice
110604
B-NDG hSIRPA mice
Maintain progenitor capacity
120612
B-NDG hIL7/hIL15 mice
Promote differentiation of human T cells and NK cells
110603
B-NDG hSIRPA/hCD47 mice
Evaluation of pharmacodynamic and toxicity of CD47, SIRPA targeted drugs
120609
B-NDG hCSF1/hTHPO mice
Promote differentiation of human myeloid cells without irradiation
112889
B-NDG hFLT3LG, Flt3 KO mice
113385
B-NDG hIL2 mice
112863
huHSC-B-NDG hCSF1/hTHPO mice
112484
huPBMC-B-NDG B2m KO mice plus
112474
B-NDG hB2M/HLA-A11.1 mice plus
112590
B-NDG Tg(RORγt-Il2rg) mice
112914
B-NDG Kit W41 mice
112874
B-NDG hB2M/HLA-A24.2 mice plus
112873
B-NDG hB2M/HLA-A3.1 mice plus
112774
B-NDG hALB/hFcRn mice
112864
huHSC-B-NDG hIL6 mice
Promote differentiation of human monocyte-macrophage
112480
huHSC-B-NDG hTHPO mice
Irradiation is not required to avoid damage to mice caused by irradiation
112479
huHSC-B-NDG MGMT3 mice
Promote differentiation of human myeloid cells;Irradiation is not required to avoid damage to mice caused by irradiation
112865
huHSC-B-NDG HLA-A2.1 mice
To verify the efficacy of HLA-A2.1 restricted vaccines;Promote the development of human CD8+ T cells
112451
B-NDG hB2M/HLA-A11.1 mice
To verify the efficacy of HLA-A11.1 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112560
B-NDG hB2M/HLA-A24.2 mice
To verify the efficacy of HLA-A24.2 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112450
B-NDG hB2M/HLA-A3.1 mice
To verify the efficacy of HLA-A3.1 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112256
B-NDG H2-K1/H2-D1 KO mice
No MHC class I molecule expression; Reduce GVHD and prolong the experimental window period; Improve the accuracy of efficacy verification
111982
B-NDG hALB mice
Used for pharmacological or pharmacokinetic studies of drugs that utilize albumin to extend their half-life
112653
B-NDG hIL15, FcγR KO mice
Promote differentiation of human NK cells;No mouse Fc receptor function
112478
huHSC-B-NDG hIL15 mice
Promote differentiation of human NK cells
112482
huNK-B-NDG hIL15 mice
Promote differentiation of human NK cells
112449
B-NDG hB2M/HLA-A2.1 mice plus
To verify the efficacy of HLA-A2.1 restricted vaccines and antibody-based therapies;Promote the development of human CD8+ T cells
112470
huHSC-B-NDG mice
Human immune system reconstitution, mainly T cells and B cells;reconstitutionl Human-derived cell or tissue engraftmentl Tumor research;Human disease model studyl Efficacy and toxicity verification for
112469
huPBMC-B-NDG mice
Human T cell reconstitution;Human-derived cell or tissue engraftment;Tumor researchl Human disease model study;Efficacy and toxicity verification for human targeted drugs
110593
B-NDG hGM-CSF mice
Promote differentiation of human myeloid cells;For mating with other humanized mice that promote myeloid cell differentiation to obtain multi-humanized mice
110598
B-NDG hairless mice
Hairless, easy to measure tumor
110597
B-NDG hIL7 mice
Promote differentiation of human lymphoid cells
110595
B-NDG H2-Ab1 KO mice
No MHC class II molecule expression; Reduce GVHD and prolong the experimental window period;Improve the accuracy of efficacy verification
111882
B-NDG MGMT3 mice
Promote differentiation of human myeloid cells;Irradiation is not required to avoid damage to mice caused by irradiatio
111895
B-NDG MHC I/II DKO mice plus
No MHC class I/II molecule expression;Reduce GVHD and prolong the experimental window period;Improve the accuracy of efficacy verification
111922
B-NDG hFcRn mice
PK (NDG background can reduce ADA)
111856
B-NDG B2m plus/hIL15 mice
Human immune system reconstitution
110605
B-NDG Hc mice
Antibody CDC function study
产品编号
常规命名
应用领域
暂无数据
立足全球生物医药行业,从技术创新出发,云顶国际建立“BioMice百奥动物”子品牌。百奥动物集创新动物模型研发制备、生产供应和实验服务为一体,拥有2800余个独特基因编辑动物/细胞系模型,覆盖肿瘤,自免,代谢等多个疾病领域。创新的动物模型、高标准的质量管理、多元化的服务平台,助推生物医药创新产业的快速发展。
联系我们
010-56967666(总机) 010-56967680(产品/技术咨询)
info@bbctg.com.cn
投资者关系联络
010-56967601
ir@bbctg.com.cn
备案号: 京ICP备10040430号-4
京公网安备: 11011502005564号
Copyright © 2024 云顶国际. All Rights Reserved
网站建设:北京分形科技